Population
Porcine coronary artery strips, anesthetized rats, rat aortic rings, and human platelets
Comparison
Trypsin and PAR-2-derived peptide (SLIGRL) vs Thrombin and thrombin receptor-derived peptide
Design
Preclinical
Authors
Loading...
Supports PAR-2-mediated vasorelaxation without pathogenic effects in animals; leaves open translation to human therapy.
PAR-2 is present on vascular endothelial cells and mediates vasorelaxation without the pathogenic properties (platelet aggregation, smooth muscle contraction) associated with the thrombin receptor.
Hwa et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: